NCT05581342

Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment

Optical Coherence Tomography for Diagnosing Recurrent Basal Cell Carcinoma After Non-invasive Treatment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Maastricht University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Superficial basal cell carcinoma (sBCC) can be treated non-invasively, but follow-up is necessary because lesions can reoccur. This study aims to evaluate the additional value of optical coherence tomography (OCT) for the detection of recurrent BCC lesions, that may remain unrecognized by clinical and dermoscopic examination (CDE). This study compared the diagnostic accuracy of CDE and CDE combined with OCT for detection of recurrent basal cell carcinoma (BCC) after non-invasive treatment of sBCC.

Conditions

• Basal Cell Carcinoma

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Punch biopsy (3mm)	In case of suspicion of recurrence or a voluntary control biopsy; a punch biopsy (3mm) was obtained conform regular care.

Timeline

• Start date: 2021-01-15
• Primary completion: 2022-03-04
• Completion: 2022-03-04
• First posted: 2022-10-14
• Last updated: 2022-10-14

Locations

1 site across 1 country: Netherlands